Virus-associated Idiopathic Thrombocytopenic Purpura

Transfusion Science - Tập 19 - Trang 253-259 - 1998
Margaret L Rand, Ph.D1, J Fraser Wright, Ph.D1,2
1Department of Biochemistry, University of Toronto, Canada.
2Pasteur Merieux Connaught, Toronto, Ontario, Canada

Tài liệu tham khảo

Harrington WJ, Minnich V, Arimura G: The autoimmune thrombocytopenias, in Tocantins M (ed.): Progress in Hematology. New York, Grune & Stratton, 1956; 166L–176L. Choi, 1967, Idiopathic thrombocytopenic purpura in childhood, Can Med Assoc, 97, 562 Najean, 1967, The platelet destruction site in thrombocytopenic purpuras, Br J Haematol, 13, 409, 10.1111/j.1365-2141.1967.tb08755.x McMillan, 1981, Chronic idiopathic thrombocytopenic purpura, N Engl J Med, 304, 1135, 10.1056/NEJM198105073041904 Kelton, 1982, Autoimmune platelet destruction: Idiopathic thrombocytopenic purpura, Semin Thromb Haemost, 8, 83, 10.1055/s-2007-1005045 Rosenfeld, 1985, Human platelet Fc receptor for immunoglobulin G: Identification as a 40,000-molecular-weight membrane protein shared by monocytes, J Clin Invest, 76, 2317, 10.1172/JCI112242 Kelton, 1987, Platelet IgG Fc receptor, Am J Hematol, 25, 299, 10.1002/ajh.2830250310 Karpatkin, 1997, Autoimmune (idiopathic) thrombocytopenic purpura, Lancet, 359, 1531, 10.1016/S0140-6736(96)12118-8 McMillan, 1971, Immunoglobulin associated with human platelets, Blood, 37, 316, 10.1182/blood.V37.3.316.316 Luiken GA, McMillan R, Lightsey AL, et al.: Platelet associated IgG in immune thrombocytopenic purpura. Blood 1977; 50:317-325. McMillan, 1980, The demonstration of antibody binding to platelet-associated antigens in patients with immune thrombocytopenic purpura, Blood, 56, 993, 10.1182/blood.V56.6.993.993 Follea, 1982, Simultaneous enzymo-immunologic assays of platelet-associated IgG, IgM and C3. A useful tool in assessment of immune thrombocytopenias, Thromb Res, 26, 249, 10.1016/0049-3848(82)90289-4 Winiarski, 1983, Platelet associated immunoglobulins and complement in idiopathic thrombocytopenic purpura, Clin Exp Immunol, 53, 201 Borne AEGKv: Autoimmune thrombocytopenia, in Engelfriet CP, Loghem JJv, Borne AEGKv (eds): Immunohaematology. Amsterdam, Elsevier, 1984; 222–256. Blanchette, 1985, Evaluation of a simple immunodiffusion technique for quantitation of platelet-associated immunoglobulin G in childhood immune thrombocytopenias, Am J Ped Hematol Oncol, 7, 125 Panzer, 1986, Platelet-associated immunoglobulins IgG, IgM, IgA and complement C3 in immune and nonimmune thrombocytopenic disorders, Am J Hematol, 23, 89, 10.1002/ajh.2830230203 Imbach, 1994, Harmful and beneficial antibodies in immune thrombocytopenic purpura, Clin Exp Immunol, 97, 25 Winiarski, 1989, IgG and IgM antibodies to platelet membrane glycoprotein antigens in acute childhood idiopathic thrombocytopenic purpura, Br J Haematol, 73, 88, 10.1111/j.1365-2141.1989.tb00225.x Wright J.F., Blanchette V.S., Wang H, et al.: Characterization of platelet-reactive antibodies in children with varicella-associated acute immune thrombocytopenic purpura (ITP). Br J Haematol 1996; 95:145-152. Mayer, 1996, Varicella-associated thrombocytopenia: Autoantibodies against platelet surface glycoprotein V, Pediatr Res, 40, 615, 10.1203/00006450-199610000-00017 Beardsley, 1984, Platelet membrane glycoprotein IIIa contains target antigens that bind anti-platelet antibodies in immune thrombocytopenias, J Clin Invest, 74, 1701, 10.1172/JCI111587 Berchtold, 1989, Autoantibodies against platelet membrane glycoproteins in children with acute and chronic immune thrombocytopenic purpura, Blood, 74, 1600, 10.1182/blood.V74.5.1600.1600 Berchtold, 1993, Autoantibodies against platelet glycoproteins in autoimmune thrombocytopenic purpura: Their clinical significance and response to treatment, Blood, 81, 1246, 10.1182/blood.V81.5.1246.1246 Woods V.L., Kurata Y, Montgomery R.R., et al.: Autoantibodies against platelet glycoprotein Ib in patients with chronic immune thrombocytopenic purpura. Blood 1984; 64:156–160 Woods, 1984, Autoantibodies against the platelet glycoprotein IIb–IIIa complex in patients with chronic ITP, Blood, 63, 368, 10.1182/blood.V63.2.368.368 Hansson, 1989, Immune mechanisms in atherosclerosis, Arteriosclerosis, 9, 567, 10.1161/01.ATV.9.5.567 Imbach P, Tani P, Berchtold W, et al.: Different forms of chronic childhood thrombocytopenic purpura defined by antiplatelet autoantibodies. J Pediatr 1991; 118:535-539. Taub, 1995, Characterization of autoantibodies against the platelet glycoprotein antigens IIb/IIIa in childhood idiopathic thrombocytopenic purpura, Am J Hematol, 48, 104, 10.1002/ajh.2830480207 Stricker, 1987, Evidence that a 210,000-molecular-weight glycoprotein (GP210) serves as a platelet Fc receptor, J Clin Invest, 79, 1589, 10.1172/JCI112993 Louache F, Bettaieb A, Henri A, et al.: Infection of megakaryocytes by human immunodeficiency virus in seropositive patients with immune thrombocytopenic purpura. Blood 1991; 78:1697–1705. Ballem PJ, Belzberg A, Devine DV, et al..: Kinetic studies of the mechanism of thrombocytopenia in patients with human immunodeficiency virus infection. N Engl J Med 1992; 327:1779–1784. Espinoza, 1974, Viral infection of megakaryocytes in varicella with purpura, Am J Clin Pathol, 61, 203, 10.1093/ajcp/61.2.203 Kitamura K, Ohta H, Ihara T, et al.: Idiopathic thrombocytopenic purpura after human herpesvirus 6 infection. Lancet 1994; 344:830. Morse, 1966, Thrombocytopenic purpura following rubella infection in children and adults, Arch Intern Med, 117, 573, 10.1001/archinte.1966.03870100101018 Perlman, 1934, Purpura and cerebral manifestations following measles, Arch Pediatr, 51, 596 Smith, 1967, Purpura fulminans complicating varicella: Recovery with low molecular weight dextran and steroids, Med J Aust, 2, 685, 10.5694/j.1326-5377.1967.tb74166.x Lopez, 1970, Thrombocytopenic purpura and chickenpox, Clin Pediatr, 9, 100, 10.1177/000992287000900215 Fernbach, 1973, Bleeding and infection, Am J Dis Child, 125, 900 Feusner, 1979, Mechanisms of thrombocytopenia in varicella, Am J Hematol, 7, 255, 10.1002/ajh.2830070308 Ho-Yen, 1984, Varicella-induced thrombocytopenia, J Infect, 8, 274, 10.1016/S0163-4453(84)94147-1 Ware, 1988, Chronic immune-mediated thrombocytopenia after varicella infection, J Pediatr, 112, 742, 10.1016/S0022-3476(88)80693-0 Winiarski, 1989, Platelet antigens in varicella associated thrombocytopenia, Arch Dis Child, 65, 137, 10.1136/adc.65.1.137 Grossman, 1959, Acute thrombocytopenic purpura in infectious mononucleosis, JAMA, 171, 2208, 10.1001/jama.1959.73010340001013 Terada, 1966, Interaction of influenza virus with blood platelets, Blood, 28, 213, 10.1182/blood.V28.2.213.213 Ellaurie, 1988, Thrombocytopenia and human immunodeficiency virus in children, Pediatrics, 82, 905, 10.1542/peds.82.6.905 Kouri, 1993, Human megakaryocytes have a CD4 molecule capable of binding human immunodeficiency virus-1, Blood, 81, 2664, 10.1182/blood.V81.10.2664.bloodjournal81102664 Oski, 1966, Effect of live measles vaccine on the platelet count, N Engl J Med, 275, 352, 10.1056/NEJM196608182750703 Asano Y, Itakura N, Hiroishi Y, et al.: Viral replication and immunologic responses in children naturally infected with varicella-zoster virus and in varicella vaccine recipients. J Infect Dis 1985; 152:863–867 Autret, 1996, Purpura thrombopénique après vaccination isolée ou associée contre la rougeole, la rubéole et les oreillons, Therapie, 5, 677 Hirsch, 1951, Dameshek W: “Idiopathic” thrombocytopenia, Arch Intern Med, 88, 701, 10.1001/archinte.1951.03810120002001 Yeager, 1980, Varicella-associated thrombocytopenia: Clues to the etiology of childhood idiopathic thrombocytopenic purpura, Johns Hopkins Med J, 146, 270 Srivastava A, Bruno E, Briddell R, et al.: Parvovirus B19-induced perturbation of human megakaryocytopoiesis in vitro. Blood 1990; 76:1997–2004. Jerushalmy, 1961, Interaction of myxoviruses with human blood platelets in vitro, Proc Soc Exp Biol Med, 106, 462, 10.3181/00379727-106-26370 Lee, 1993, Effect of platelet-associated virus on assays of HIV-1 in plasma, Science, 262, 1585, 10.1126/science.8248811 Kazatchkine, 1984, Membrane-bound hemagglutinin mediates antibody and complement-dependent lysis of influenza virus-treated human platelets in autologous serum, J Clin Invest, 74, 976, 10.1172/JCI111518 Campana D, Bergui L, Camussi G, et al.: Immune-complexes and anti-platelet antibodies in idiopathic thrombocytopenic purpura. Haematologica 1983; 68:157–166 Kurata Y, Hayashi S, Aochi H, et al.: Analysis of antigen involved in circulating immune complexes in patients with idiopathic thrombocytopenic purpura. Clin Exp Immunol 1987; 67:293–299 Puram, 1984, Circulating immune complexes and platelet IgG in various diseases, Clin Exp Immunol, 58, 672 Scott S, Reimers H-J, Cherneskey MA, et al.: Effects of viruses on platelet aggregation and platelet survival in rabbits. Blood 1978; 52:47–55. Bettaieb A, Fromont P, Louache F, et al.: Presence of cross-reactive antibody between human immunodeficiency virus (HIV) and platelet glycoproteins in HIV-related immune thrombocytopenic purpura. Blood 1992; 80:162–169. Rand ML, Wright JF, Blanchette VS, et al.: Platelet-reactive antibodies in children with immune thrombocytopenic purpura (ITP) associated with Epstein–Barr virus (EBV) infection. Blood 1996; 88(Suppl 1):516a. Karpatkin, 1992, Autoimmune anti-HIV-1 GP120 antibody with antiidiotype-like activity in sera and immune complexes of HIV-1-related immunologic thrombocytopenia, J Clin Invest, 89, 356, 10.1172/JCI115593 Schwimmbeck, 1989, Molecular mimicry and myasthenia gravis: An autoantigenic site of the acetylcholine receptor alpha-subunit that has biological activity and reacts immunochemically with herpes simplex virus, J Clin Invest, 84, 1174, 10.1172/JCI114282